SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease

• SIRT7-deficient mice develop hepatosteatosis resembling human fatty liver disease
• SIRT7 activation is a critical event in UPRER to alleviate ER stress
• Myc recruits SIRT7 to repress ribosomal protein genes and to suppress ER stress
• SIRT7 reverts fatty liver associated with diet-induced obesity

SummaryNonalcoholic fatty liver disease is the most common chronic liver disorder in developed countries. Its pathogenesis is poorly understood, and therapeutic options are limited. Here, we show that SIRT7, an NAD+-dependent H3K18Ac deacetylase, functions at chromatin to suppress ER stress and prevent the development of fatty liver disease. SIRT7 is induced upon ER stress and is stabilized at the promoters of ribosomal proteins through its interaction with the transcription factor Myc to silence gene expression and to relieve ER stress. SIRT7-deficient mice develop chronic hepatosteatosis resembling human fatty liver disease. Myc inactivation or pharmacological suppression of ER stress alleviates fatty liver caused by SIRT7 deficiency. Importantly, SIRT7 suppresses ER stress and reverts the fatty liver disease in diet-induced obese mice. Our study identifies SIRT7 as a cofactor of Myc for transcriptional repression and delineates a druggable regulatory branch of the ER stress response that prevents and reverts fatty liver disease.

Graphical AbstractFigure optionsDownload as PowerPoint slide